Computer-Assisted Provision of Reproductive Health Care

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Eleanor Bimla Schwarz, University of Pittsburgh

ClinicalTrials.gov Identifier:

NCT00829517

First received: January 23, 2009

Last updated: February 15, 2012

Last verified: February 2012

History of Changes

Purpose

This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study will be a randomized controlled trial which will evaluate the use of a computer kiosk module to compare the proportion of women of reproductive age who receive a prescription for hormonal contraception when computer-assisted provision of hormonal contraception is offered (intervention) to encounters when the study clinic provides standard contraceptive care (control). Subjects will be contacted approximately 3 months (range 2-4 months) after the clinic visit to complete a follow-up phone interview. The study population will include English and Spanish-speaking women ages 18-45 who seek care at this clinic. Our hypothesis is that computer-assisted provision of hormonal contraception (intervention)will increase the proportion of women of reproductive age who receive a prescription for hormonal contraception versus standard contraceptive care(control).

Condition	Intervention
Contraception Sexually Transmitted Diseases	Other: computer-assisted provision of hormonal contraception Other: STI module


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Health Services Research
Official Title:	Computer-Assisted Provision of Reproductive Health Care

Resource links provided by NLM:

MedlinePlus related topics: Birth Control Sexually Transmitted Diseases

U.S. FDA Resources

Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:

self-reported use of hormonal or more effective contraception [ Time Frame: 3 months ] [ Designated as safety issue: No ]
receipt of screening for sexually transmitted infection [ Time Frame: 3 months ] [ Designated as safety issue: No ]


Enrollment:	814
Study Start Date:	January 2011
Study Completion Date:	November 2011
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Active Comparator: STI kiosk computer-assisted provision of screening for chlamydia	Other: STI module computer module available at a kiosk that will encourage women to be screened for chlamydia Other Name: Chlamydia kiosk
Experimental: contraceptive kiosk computer-assisted provision of hormonal contraception	Other: computer-assisted provision of hormonal contraception a computer program available at a kiosk will offer women information about and a prescription for hormonal contraception that they can ask their clinician to sign. Other Name: Family planning kiosk

Detailed Description:

Data collection has been completed

Eligibility


Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

women who speak English or Spanish who visit a study clinic

Exclusion Criteria:

women who do not speak English or Spanish

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00829517

Locations


United States, California
University of California, San Francisco
San Francisco, California, United States, 94122
United States, Pennsylvania
UPMC
Pittsburgh, Pennsylvania, United States, 15213

Sponsors and Collaborators

University of Pittsburgh

Investigators


Principal Investigator:	Eleanor B Schwarz, MD, MS	University of Pittsburgh

More Information

No publications provided


Responsible Party:	Eleanor Bimla Schwarz, Associate Professor of Medicine, University of Pittsburgh
ClinicalTrials.gov Identifier:	NCT00829517 History of Changes
Other Study ID Numbers:	SFP2-8
Study First Received:	January 23, 2009
Last Updated:	February 15, 2012
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Pittsburgh:


Contraception sexually transmitted diseases

Additional relevant MeSH terms:


Sexually Transmitted Diseases Genital Diseases, Female Genital Diseases, Male Infection Virus Diseases

ClinicalTrials.gov processed this record on March 03, 2015

To Top